Latest news
AbCellera Biologics Sees Unusually High Options Volume (NASDAQ:ABCL) - MarketBeatMarketBeat · Mon, 10 Aug 2026 15:14:33 GMTADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law - businesswire.combusinesswire.com · Mon, 10 Aug 2026 14:16:00 GMTCLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026 - AOL.comAOL.com · Mon, 10 Aug 2026 12:51:29 GMTADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP By Application Deadline - PR NewswirePR Newswire · Mon, 10 Aug 2026 12:30:00 GMTAbCellera Biologics Inc. (NASDAQ:ABCL) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.stsimplywall.st · Mon, 10 Aug 2026 11:08:53 GMTADMA Biologics 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA - businesswire.combusinesswire.com · Fri, 07 Aug 2026 22:02:00 GMTADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 19:26:00 GMTADMA Biologics Deadline: Rosen Law Firm Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA - businesswire.combusinesswire.com · Fri, 07 Aug 2026 18:17:00 GMT